IFGL Refractories Indigenously manufactured Orbital Implants in India

Image
Announcement Corporate
Last Updated : Jan 29 2013 | 2:16 AM IST

IFGL Refractories Limited (IFGL) has set up a modern facility for the manufacture of Bio Ceramics in which Orbital Implants based on synthetic porous Hydroxyapatite material are also manufactured, These are marketed under the trade name CeraEye.

CeraEye manufactured as per the Patented technology (Indian Patent no. 197588) developed by Central Glass & Research Institute, Kolkata (CGCRI) is regularly being used by reputed eye surgeons and leading eye hospitals like Sankara Nethralaya, Disha Eye Hospitals & Research Centre, Sankardeva Nethralaya, Sir Ganga Ram Hospital, Arvind Eye Hospitals, Regional Institute of Opthalmology, Medical College, Peerless Hospitals, Rotary Narayan Nethralaya, Susrut Eye Foundation & Research Centre, Wockhardt Eye Hospitals, R G Kar Medical College etc in India.

CeraEye, as a hydroxyapatite based ocular implant, substitutes lost natural eye ball either due to disease / accident or otherwise. Since CeraEye is based on Hydroxyapatite material and is engineered to be 75% porous with pore sizes ranging from 100 to 300 microns, it provides for vascularisation. As a result, within six months of surgery, tissues and blood vessels encompass it and thus enable good movement. Structure of porous model permits fibro vascular growth into the prosthetic facilitating stability within the eye socket.

The clinical performance of CeraEye Orbital implants which are far better than the available ones made of materials such as metal, glass, polymer etc which have been found to be not only incompatible with the host but also static. The clinical study also confirms that socket remains very healthy even after a long period of post operative study and subsequently it gives a better implant and prosthesis motility is very good in this case. Salient features of CeraEye are:

 

 

  • Ceramic matrix acting as a medium for soft tissue ingrowths.
  • Light in weight
  • Simple design
  • Smaller than an eye ball
  • Centered within muscle cone
  • Integration to EO muscle
  • Anchored to orbital tissue
  • Resists migration and provides permanent stability
  • High strength and can be drilled for fitting of motility peg
  • Provides much more movement than conventional prosthesis
  • Incidence of lower lid sagging is minimized

    CeraEye is produced under processes having ISO 9001: 2000 and CE (CE 1023) Certifications. It is available in sizes from 12 mm to 20 mm, both in spherical/conoid design. The conoid design is in plain model and drilled hole model for evisceration/enucleation purpose. Implants are supplied in special air tight plastic containers after Gamma Ray sterilization treatment and is marketed by IFGL Bio Ceramics Limited www.ifglbioceramics.com

  •  

    *Subscribe to Business Standard digital and get complimentary access to The New York Times

    Smart Quarterly

    ₹900

    3 Months

    ₹300/Month

    SAVE 25%

    Smart Essential

    ₹2,700

    1 Year

    ₹225/Month

    SAVE 46%
    *Complimentary New York Times access for the 2nd year will be given after 12 months

    Super Saver

    ₹3,900

    2 Years

    ₹162/Month

    Subscribe

    Renews automatically, cancel anytime

    Here’s what’s included in our digital subscription plans

    Exclusive premium stories online

    • Over 30 premium stories daily, handpicked by our editors

    Complimentary Access to The New York Times

    • News, Games, Cooking, Audio, Wirecutter & The Athletic

    Business Standard Epaper

    • Digital replica of our daily newspaper — with options to read, save, and share

    Curated Newsletters

    • Insights on markets, finance, politics, tech, and more delivered to your inbox

    Market Analysis & Investment Insights

    • In-depth market analysis & insights with access to The Smart Investor

    Archives

    • Repository of articles and publications dating back to 1997

    Ad-free Reading

    • Uninterrupted reading experience with no advertisements

    Seamless Access Across All Devices

    • Access Business Standard across devices — mobile, tablet, or PC, via web or app

    More From This Section

    First Published: Sep 05 2008 | 12:00 AM IST

    Next Story